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Clinical isolates of Yersinia, Klebsiella, and Escherichia coli
frequently secrete the small molecule metallophore yersiniabac-
tin (Ybt), which passivates and scavenges transition metals dur-
ing human infections. YbtT is encoded within the Ybt biosyn-
thetic operon and is critical for full Ybt production in bacteria.
However, its biosynthetic functionhas beenunclear because it is
not essential for Ybt production by the in vitro reconstituted
nonribosomal peptide synthetase/polyketide synthase (NRPS/
PKS) pathway. Here, we report the structural and biochemical
characterization of YbtT. YbtT structures at 1.4–1.9 Å reso-
lution possess a serine hydrolase catalytic triad and an asso-
ciated substrate chamber with features similar to those previ-
ously reported for low-specificity type II thioesterases (TEIIs).
We found that YbtT interacts with the two major Ybt biosyn-
thetic proteins,HMWP1 (high-molecular-weight protein 1) and
HMWP2 (high-molecular-weight protein 2), and hydrolyzes a
variety of aromatic and acyl groups from their phosphopanteth-
einylated carrier protein domains. In vivo YbtT titration in uro-
pathogenic E. coli revealed a distinct optimum for Ybt produc-
tion consistent with a tradeoff between clearing both stalled
inhibitory intermediates and productive Ybt precursors from
HMWP1 and HMWP2. These results are consistent with a
model in which YbtT maintains cellular Ybt biosynthesis by
removing nonproductive, inhibitory thioesters that form aber-
rantly at multiple sites on HMWP1 and HMWP2.
The YersiniaHigh Pathogenicity Island (HPI)6 is a virulence-
associated,mobile genetic element found in a number ofGram-
negative pathogens, including Yersinia pestis, Klebsiella, and
uropathogenic Escherichia coli (UPEC) (1, 2). The HPI encodes
a hybrid nonribosomal peptide synthetase/polyketide synthase
(NRPS/PKS) pathway that produces yersiniabactin (Ybt), a
small molecule metallophore initially recognized for its role in
Fe(III) uptake andmore recently found to engage in passivation
and uptake of copper and nickel (3–7). Related NRPS/PKS
pathways in Pseudomonas aeruginosa and Mycobacterium
tuberculosis produce structurally related siderophores that also
facilitate virulence, making these pathways possible antiviru-
lence targets (8).
NRPSs and PKSs are large multidomain enzymes found in
bacteria and fungi that produce an immense variety of chemi-
cally diverse secondary, or specialized, metabolites. Often lik-
ened to an assembly line, these pathways produce complex
products from simple precursor molecules, such as amino
acids, aryl acids, and acyl-CoAs.NRPS/PKSs consist ofmodules
that incorporate one precursor into the elongatingmolecule by
a series of condensation and modification reactions that are
catalyzed by individual domains. Pathway intermediates are
covalently attached to dedicated carrier protein domains (CPs)
through a thioester bond to the domain’s phosphopantetheine
(ppant) post-translational modification. The finished products
are released from the final CP by a terminal type I thioesterase
domain (TEI) present in HMWP1 (9, 10).
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TheYbt biosynthetic pathway has been reconstituted in vitro
with four proteins that are encoded in a single operon on the
Yersinia HPI: YbtE, HMWP2, HMWP1, and YbtU (3). Biosyn-
thesis begins when the adenylation enzyme YbtE loads salicylic
acid onto the first CP of a 230-kDa NRPS called HMWP2.
HMWP2 then condenses and cyclizes this salicylic acid unit
with 2 units of L-cysteine. The resulting intermediate is next
transferred toHMWP1, a 350-kDa hybridNRPS/PKS that adds
a malonyl group from malonyl-CoA, another L-cysteine, and
three methyl groups from S-adenosylmethionine (SAM). Next,
the reductase YbtU acts on an HMWP1-bound intermediate
before Ybt is finally released by the TEI (11). A fifth enzyme,
YbtT, is encoded on the biosynthetic operon but is not required
for in vitro reconstitution (3). Nevertheless, ybtT deletion
mutants of Y. pestis and UPEC exhibit severe Ybt production
defects (12–14). YbtT possesses a conserved Gly–His–Ser–
Xaa–Gly thioesterase motif and is homologous to a class of
NRPS/PKS-associated enzymes called type II thioesterases. To
date, YbtT has not been biochemically characterized.
Type II thioesterases (TEIIs) are a family of NRPS/PKS-
associated enzymes to which a variety of functions has been
ascribed (15). The most common and well-understood func-
tion is to edit NRPSs and PKSs by removing nonelongatable
precursors and intermediates from the CP domains. These
erroneous molecules on CPs inhibit the assembly line, and
regeneration of the free thiol on the ppant by aTEII salvages the
NRPS or PKS for further rounds of biosynthesis. TEII-mediated
editing is supported by in vivo reduced product levels in TEII
deletion mutants and by in vitro biochemical characterizations
in which TEIIs were shown to hydrolyze small molecules from
thioester substrates (15–17). Substrate profiling results from
these studies are largely consistent with a role in removing non-
elongatable “mistakes,” although in a few cases in vitro and in
vivo data suggest another function, such as end product release
(18, 19), intermediate release (20), or provision of a key inter-
mediate to a downstream biosynthetic protein (21–23).
Here, we report the first structural and biochemical charac-
terization of YbtT. Crystal structures of E. coli YbtT reveal the
/ hydrolase fold and catalytic triad typical of TEIIs. Purified
YbtT is an active thioesterase that interacts with HMWP1 and
HMWP2. Using LC-MS–based approaches, we found that
YbtT cleaves both cognate and noncognate Ybt precursors
from acyl-CP domains. YbtT substrate specificity is consistent
with an editing activity, the most commonly understood TEII
function. The presence of a YbtT activity optimum during in
vivo and in vitro Ybt biosynthesis is consistent with a low-spec-
ificitymodel of editing (17) inwhich futile hydrolysis of produc-
tive precursors competes with restorative hydrolysis of inhibi-
tory thioesters. Optimal Ybt production may thus require a
favorable balance between these opposing activities.
Results
YbtT and YbtT–S89A crystal structures
To provide a framework for understanding YbtT function,
we crystallizedWTYbtT and determined the structure at 1.9 Å
resolution (Table 1). YbtT adopts an / hydrolase fold with
core and lid subdomains (Fig. 1A). The core comprises a six-
stranded parallel -sheet encompassed by five -helices, and
the lid (residues 125–173) is formed by three-helices inserted
between 4 and 5 of the core. Analysis for structural neigh-
bors using the DALI server (24) revealed that YbtT shares the
highest structural homology with TEIIs from otherNRPS path-
ways: RedJ from Streptomyces coelicolor (32% sequence iden-
tity) (22) and RifR from Amycolatopsis mediterranei (28%
sequence identity) (25). It also shares homology with a human
TEII associated with fatty acid biosynthesis (22% sequence iden-
tity) (Figs. 2,A and B, and 8A) (26). The active site is composed of
the conserved serine hydrolase catalytic triad of Ser-89, His-225,
andAsp-197 (Fig. 1B). The catalytic nucleophile, Ser-89, is located
adjacent to the lid domain between strand 3 and helix 3 in the
conserved thioesterase motif Gly–His–Ser–Xaa–Gly (Gly-87–
His-88–Ser-89–Met-90–Gly-91). The backbone amides of
Met-90 and Ala-22 form the oxyanion hole, which serves to
stabilize the negative charge that accumulates on the transition
state during catalysis. A water molecule occupies the oxyanion
hole in the crystal structure. In context with its genetic associ-
ations in the Ybt biosynthetic operon, this structure suggests
that YbtT functions as a TEII and identifies residues that may
be essential for enzymatic activity.
A previous study revealed that alanine substitution mutants
in the analogous Y. pestis YbtT Ser and His active-site residues
could not complement iron-restricted growth of a ybtT knock-
out strain (13). To determine whether this defect specifically
reflects loss of catalytic residues or derives frommore extensive
structural distortion, we crystallized and determined the
structure of YbtT–S89A to 1.4 Å resolution. The YbtT–S89A
mutant adopts an overall structure very similar to WT, with a
C RMSD of 0.2 Å (Fig. 1A). A minor difference was noted in
the orientation of the catalytic triad residues, with the His-225
Table 1
Crystallographic statistics for E. coli UTI89 YbtT
Variant WT S89A
Data collection statistics
Space group P4212 P4212
Unit cell (Å) a 82.3 a 82.5
b 82.3 b 82.5
c 81.9 c 82.0
Source ALS 4.2.2 ALS 4.2.2
Wavelength (Å) 1.0000 1.0000
Resolution (Å) 58.2–1.90 (1.94-) 58.3–1.40 (1.42-)
Rmerge (%) 15.4 (389) 6.5 (187)
CC1/2 0.997 (0.344) 1.000 (0.303)
Completeness (%) 100 (100) 98.9 (88.0)
Redundancy 11.8 (9.9) 11.9 (5.0)
I/ (I) 11.2 (0.6) 22.5 (0.7)
Refinement statistics
Rwork (%) 19.4 16.6
Rfree (%) 22.5 18.0
Amino acid residues (#) 249 249
Waters (#) 209 298
RMSD bond length (Å)/angles (°) 0.007/0.886 0.008/0.974
Wilson B (Å2) 30.1 16.8
Average B protein (Å2) 31.6 21.2
Average B water (Å2) 39.5 33.6
Ramachandran
%Favored 98.0 97.6
%Allowed 2.0 2.4
%Outliers 0 0
Rotamer outliers 0 1
Clashscore 2.86 2.08
Molprobity 1.08 1.00
Luzzati error 0.256 0.150
PDB codes 6BA8 6BA9
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imidazole ring in the YbtT–S89A structure flipped relative to
its WT orientation (Fig. 1, B and C). Thus, the S89A mutation
did not result in any gross structural changes to YbtT.
Structural comparison of YbtT active site with other
NRPS/PKS TEIIs
Previous structural and enzymatic studies of NRPS TEIIs
identified active-site features that may contribute to substrate
specificity and enzyme function. Differences in substrate spec-
ificity between S. coelicolor RedJ and A. mediterranei RifR have
been attributed to residues lining the substrate chamber, which
emanate mostly from L1 and L3 of the lid domain. In RedJ,
these residues are predominantly hydrophobic and at least par-
tially explain its high specificity for substrates with long acyl
chains, as opposed to short ones (22). In contrast, several resi-
dues lining this pocket in RifR are occupied by polar residues, a
feature that likely contributes to the enzyme’s low substrate
specificity (25). Given these previous observations, we com-
pared residues lining the substrate chamber of YbtT with those
of RedJ and RifR for potential functional insights. We found
that a number of the positions occupied by hydrophobic resi-
dues in RedJ were occupied by charged residues (Arg or Glu) in
YbtT (Fig. 2, A and C, denoted by *). In addition, half of the
positions occupied by polar residues in RifR were conserved in
YbtT (Fig. 2, B andD, denoted by *). This analysis suggests that
the substrate chamber of YbtT more closely resembles that of
RifR, an enzyme that functions as a low-specificity editing TEII,
suggesting that YbtTmaydisplay similar function and substrate
promiscuity.
YbtT flexible lid domain is in an open conformation
Previous structural studies of NRPS TEIIs, both in crystals
and in solution, suggest that the lid domain is conformationally
flexible and thereby controls substrate access to the active site
(22, 25, 27). Indeed, the crystal structures of both RifR and RedJ
display multiple lid domain conformations. For RifR, all of the
structures display a closed ppant entrance, whereas for RedJ,
both open and closed conformations were observed. In YbtT,
the L2 helix is noticeably shifted away from the active site,
leaving the lid domain in an open conformation (Fig. 3A).
Atomic displacement parameter (B-factor) analysis suggests
that the YbtT open conformation is likely stabilized by crystal
contacts because the B-factors in the lid domain of YbtT are
only slightly elevated relative to the core domain. In contrast,
the RedJ open conformation displays much higher lid domain
B-factors relative to the core (Fig. 3A). In the closed conforma-
tions of RedJ and RifR, the lid domains also display similar
B-factors to the core, likely attributable to several contacts
between the lid and core. Comparative cavity and tunnel anal-
ysis in CAVER (28, 29) revealed that YbtT has an open ppant
entrance that more closely resembles the RedJ open conforma-
tion than the blocked ppant entrances of the closed RedJ and
Figure 1. Structure of E. coliUTI89 YbtTWT and S89Amutant. A, cartoon trace of E. coliUTI89 YbtTWT (magenta) and S89A (light pink) crystal structures. A
water molecule found in the oxyanion hole of the active site of each structure is shown (red sphere) to mark the location of the active site. Lid and core
subdomains are denoted. B and C, active site of YbtT WT (B) and S89A (C). Side chains of the catalytic triad (Ser-89, Asp-197, and His-225) and all atoms of the
oxyanion hole residues (Ala-22 andMet-90) are shown as sticks colored as follows: carbon (magenta/light pink); oxygen (red); nitrogen (blue); sulfur (yellow). A
watermolecule found in each structure in the oxyanionhole is shownas a red sphere. Potential hydrogenbonds are shownas yellowdashes (distances denoted
in Å).
Figure2.ComparisonofYbtT tohybridNRPS/PKSTEIIs.A andB, overlayof
the crystal structures of YbtT WT (magenta) with S. coelicolor RedJ (cyan, PDB
code 3QMV) (A) and A. mediterranei RifR (green, PDB code 3FLB) (B). -Helices
that compose the lid subdomain are denoted. The water molecule (red
sphere) that occupies the oxyanion hole of the active site is shown for refer-
ence. C, comparison of residues that line the active-site pockets of YbtT and
RedJ. Hydrophobic residues lie at these positions in RedJ, and in YbtT some
are hydrophobic and others are charged (denoted by *). Hydrophobic resi-
dues are colored with carbon atomsmagenta (YbtT) and cyan (RedJ). Carbon
atoms of charged residues are colored dark gray. Other atoms colored by
element are as in Fig. 1. D, comparison of polar residues that line the active-
site pocket in YbtT and RifR. Polar residues lie at these positions in RifR, and in
YbtT some are polar (denoted by *) and some are hydrophobic. Coloring is as
in C.
YbtT structure and function
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RifR lid subdomain structures (Fig. 3B). The open conforma-
tions of YbtT and RedJ displayed the largest active site cavities
(756 and 705 Å3, respectively) compared with the closed con-
formations of RedJ and RifR (568 and 682 Å3, respectively).
Tunnel analysis indicated that the active sites of YbtT and RedJ
(open) are accessible from the putative ACP-binding surfaces,
whereas RedJ (closed) and RifR are not (Fig. 3B). Together, this
analysis indicates that our YbtT structure crystallized in an
open conformation that displays external access to the active
site.
YbtT is an active hydrolase
To determine whether YbtT possesses hydrolase activity, we
incubated purified YbtT with the esterase substrates p-nitro-
phenyl (p-NP) acetate and p-NP butyrate (Fig. 4A) under
steady-state conditions. p-NP esters have been widely used to
investigate the in vitro activity and substrate specificity of TEIIs
(15, 17, 30). Hydrolysis was measured continuously for 10 min,
during which time less than 10% of the substrate was converted
into product, and the appearance of product was linear as a
function of time. YbtT hydrolyzed both esterase substrates,
confirming its predicted activity as a hydrolase (Fig. 4B and
Table 2). The relative velocity of the reaction was proportional
to YbtT concentration with both p-NP acetate and p-NP butyr-
ate (Fig. S1). The poor solubility of p-NP butyrate limited the
concentrations that could be tested such that only a kcat/Km
value could be estimated. YbtT was inactive with the protease
substrate glycine p-nitroanilide (Fig. 4, A and C). The catalytic
efficiency of YbtT was low for both p-NP substrates (kcat/Km
50 M1 s1) compared with other TEIIs tested with the same
substrates (15). These esterase substrates are structurally dis-
similar from YbtT’s hypothesized substrate, an acylated CP,
which may contribute to the low measured catalytic efficien-
cies. Thesemodel substrate results demonstrate that YbtT is an
active hydrolase.
YbtT serine hydrolase catalytic triad is necessary for activity
To test the hypothesized roles of the serine (Ser-89), histidine
(His-225), and aspartic acid (Asp-197) catalytic triad residues in
hydrolase activity, we constructed single Ala substitutions at
each residue and tested them for hydrolase activity with p-NP
acetate. YbtT–H225A andYbtT–D197Adisplayed elution pro-
files on a gel-filtration column identical to WT and YbtT–
S89A, suggesting that thesemutations did not grossly alter pro-
tein structure (Fig. S2). All three catalytic triad mutants were
unable to hydrolyze p-NP acetate (Fig. 4C). Phenylmethylsulfo-
nyl fluoride (PMSF), a general covalent inhibitor of serine
hydrolases, inhibits YbtT activity, as has been shown for other
Figure 3. YbtT active site access compared with other hybrid NRPS/PKS TEIIs. A, comparison of B-factor distributions and different lid conformations in
NRPS/PKS TEII crystal structures. Ribbon structures are colored according to average residue B-factor (blue 20white red 50 Å2). Position of the active
site is denoted by the water occupying the oxyanion hole (red sphere). The following structures were used for the analysis: RedJ-open  3QMV chain C;
RedJ-closed 3QMWchain B; RifR-closed 3FLB. B, comparison of ppant entrance tunnels and cavities. Analysis was performed using CAVER (28, 29). Cavities
are shown in surfacemodeandcoloredgray. Themost probable tunnels to the active site from the surfacedetectedbyCAVERare shown indark blue. Locations
where tunnels emerge to surface are denoted by asterisks and gradient triangle. Note that YbtT and RedJ are both open at the ppant entrance, whereas
RedJ-closed and RifR-closed are not, but they are instead open to a surface displaced about 90° from the putative ppant entrance. Lid subdomains are colored
lighter than core subdomains. Cavity volumes calculated by CAVER are: YbtT 756 Å3; RedJ-open 705 Å3; RedJ-closed 568 Å3; RifR-closed 682 Å3.
YbtT structure and function
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TEIIs (17). These results are consistent with the hypothesized
role for the serine hydrolase catalytic triad in YbtT hydrolase
activity.
Catalytically active YbtT restores Ybt production in a ybtT
deletionmutant
Previous work has demonstrated that ybtT deletion mutants
in Y. pestis and UPEC are deficient in Ybt production (12–14).
To further investigate the role of ybtT in UPEC, we used the
model UPEC strain UTI89 and expressed plasmid-encoded
YbtT in UTI89ybtT and monitored Ybt production by LC-
MS/MS. Expression of WT ybtT, but not catalytically inactive
ybtT-S89A, partially restored Ybt production in UTI89ybtT
Figure 5. YbtT enzymatic activity is important for optimal Ybt produc-
tion, and it forms a complex with Ybt biosynthetic proteins. A, Ybt levels,
quantified by stable isotope dilution and LC-MS/MS, of UTI89, ybtT, and
ybtT strains complementedwith eitherWT ybtTor catalytically inactive ybtT-
S89A cloned into the plasmid pTrcHis2. Strains were grown under iron-re-
stricted conditions. Mean of n 3 with standard deviation plotted, one-way
ANOVA compared with multiple comparison post-test to ybtT; ***, p 
0.0001; ns, p  0.05. B, SYPRO Orange-stained SDS-polyacrylamide gel of in
vitro pulldown experiment with YbtT loaded onto nickel beads and exposed
to UTI89fur cellular lysate (lane 4). Additional sets of beads were exposed to
either YbtT only (lane 2) or lysate only (lane 3) as negative controls. Molecular
mass markers (lane 1) are indicated on the left in kDa. YbtT specifically pulled
down two proteins, which were identified as HMWP1 and HMWP2 by
LC-MS/MS.
Table 2
Kinetic parameters for YbtT hydrolysis of p-NP ester substrates
Substrate kcat Km kcat/Km
min1 mM M1 s1
p-NP acetate (OCH3) 2.25 0.09 1.5 0.1 25.3 2.1
p-NP butyrate (OCH2CH2CH3) 20.5a
a Because experiments with p-NP butyrate were limited by the substrate’s sol-
ubility, a full Michaelis-Menten analysis could not be performed. The
kcat/Km value reported was estimated from the reaction progress curve, as
described by Copeland (56).
Figure 4. YbtT hydrolyzes ester substrates with short acyl chains, and
this activity depends on Ser-89, Asp-197, and His-225. A, chemical struc-
tures of the substrates used in the activity assays. The ester and amide groups
in thep-NPesters andglycinep-nitroanilide, respectively, aremarked in red.B,
Michaelis-Menten plot for hydrolysis of p-NP acetate and butyrate. The reac-
tions were performed at 0.5 M YbtT and varying concentrations of the des-
ignated substrate. The p-NP acetate data were fit to the Michaelis-Menten
equation (R2 0.9914), and the calculated kinetic parameters are reported in
Table 2; mean of n 3 with standard error plotted. C, time courses of YbtT-
catalyzed hydrolysis of the esterase substrate, p-NP acetate, and a protease
substrate, glycinep-nitroanilide.All datahavebeennormalized toaccount for
spontaneous background hydrolysis of the substrates in the absence of
enzyme. All reactions were performed with 0.5 M enzyme and 1 mM sub-
strate. PMSF treatment was performed at 1 mM. Mean of n 3 for all condi-
tions except YbtT with glycine p-nitroanilide and YbtT  PMSF with p-NP
acetate, where n 2. Standard deviation plotted.
YbtT structure and function
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(Fig. 5A). Differences in Ybt expression were not attributable to
growth defects, as all strains grew to the same extent (Fig. S3).
These results suggest that although ybtT is not essential for
bacterial growth in culture, its serine catalytic triad plays an
important role in maximizing Ybt production.
YbtT interacts with HMWP1 and HMWP2
TEIIs hydrolyze thioester bonds that tether small molecules
to phosphopantetheinylated CPs. In addition to Ybt biosyn-
thetic enzymes, UTI89 can also express phosphopantetheiny-
lated enzymes involved in enterobactin, fatty acid, and colibac-
tin biosynthesis (31). To identify YbtT-interacting proteins, we
performed pulldown assays with recombinantly purified YbtT.
Because expression of YbtT and other phosphopantetheiny-
lated enzymes are subject to transcriptional repression by the
Fur transcription factor, we hypothesized that YbtT-binding
partners would be enriched in prey lysates from a fur deletion
mutant. YbtTwas therefore exposed toUTI89fur prey lysates,
and the eluates were analyzed by SDS-PAGE. Two exception-
ally high-molecular-weight proteins were specifically pulled
down by YbtT (Fig. 5B). In-gel trypsin digest andmass spectro-
metric analysis of the peptides revealed these proteins as
HMWP1 (350 kDa) and HMWP2 (230 kDa), the major Ybt
NRPS/PKS biosynthetic proteins. No other phosphopantethei-
nylated enzymes were detected in the pulldown. These results
are consistent with HMWP1 and HMWP2 as interacting part-
ners of YbtT.
YbtT hydrolyzes ppant thioesters of the HMWP2 aryl carrier
domain
We next sought to determine whether YbtT hydrolyzes
ppant thioesters on HMWP2. We expressed the aryl carrier
protein domain (ArCP), the first phosphopantetheinylated
domain ofHMWP2 (amino acids 1–100) and the site of salicylic
acid loading, and we enzymatically generated both aromatic
and aliphatic thioesters. Their identity was confirmed by full
scan LC-MS and the ppant ejection method (LC-MS/MS) (32,
33). Our panel of test substrates included the salicyl thioester of
ArCP, which is a canonical intermediate of Ybt biosynthesis.
After incubating each substrate with YbtT for 30 min, we used
LC-MS to detect thioester bond hydrolysis. Complete conver-
sion to the empty holo-ArCP product was observed for both
aromatic and aliphatic thioesters except anthranilyl-ArCP,
which was only partially hydrolyzed (Fig. 6B). Hydrolysis of this
chemically diverse ppant thioester series, which includes the
canonical salicyl thioester intermediate, is consistent with
broad substrate specificity for YbtT.
YbtT hydrolyzesmultiple aliphatic thioesters of the HMWP1
acyl carrier domain
To determinewhether YbtT also hydrolyzes ppant thioesters
on HMWP1, we prepared thioesters of phosphopantetheiny-
lated ACP from the HMWP1 PKS module (amino acids 1813–
1995). Here, we were limited to enzymatic synthesis of acetyl-,
hexanoyl-, and malonyl-ACP thioesters. YbtT thioesterase
activity with each ACP substrate was monitored by LC-MS, as
described for ArCP above. YbtT hydrolyzed the short and
medium length acyl chains but not malonyl-ACP, a carboxy-
lated acyl chain and a canonical Ybt biosynthetic precursor (Fig.
6C). These results demonstrate that phosphopantetheinylated
CPs necessary for both early (HMWP2) and late (HMWP1) Ybt
biosynthesis may be YbtT substrates. The reduced activity on
malonyl-ACP, relative to the other structurally related thioes-
Figure 6. MS-based assessment of YbtT’s substrate specificity for acylated CP domains. A, reaction scheme of YbtT-catalyzed hydrolysis of small mole-
cules fromphosphopantetheinylated CP domains. B and C,mass spectra of the12 charge state of holo-ArCP (B) and holo-ACP (C) that had been loadedwith
candidate small molecule substrates and incubated for 30 min with or without 1 M YbtT (right and left, respectively).
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ters, suggests somedegree of YbtT substrate selectivity that acts
to spare the canonical precursor from hydrolysis.
YbtT increases Ybt biosynthesis in the presence of a
noncanonical precursor
To determine how YbtT directly affects Ybt biosynthesis, we
added it to the in vitro reconstituted systemdeveloped byMiller
et al. (3), where no effect was observed with YbtT at 10-fold
excess over the other enzymes. The four essential enzymes for
Ybt biosynthesis, YbtE, HMWP2, HMWP1, and YbtU, were
purified and combined with the canonical precursors: salicylic
acid, L-cysteine, and malonyl-CoA. We found that L-serine, a
physiologically plausible, noncanonical precursor that struc-
turally mimics L-cysteine, inhibited Ybt production during in
vitro biosynthesis (Fig. 7A). In the presence of competing L-ser-
ine, YbtT addition at 10-fold excess over the other enzymes
restored the final Ybt yield to that observed in the absence of
L-serine. These observations suggest that YbtT edits Ybt bio-
synthetic intermediates, preventing HMWP2 and HMWP1
inactivation by misincorporated L-serine thioesters that would
otherwise irreversibly inhibit the biosynthetic pathway.
YbtT diminishes the rate of Ybt biosynthesis
YbtT slowed the initial rate of Ybt production in both the
presence and absence of L-serine (Fig. 7A). Given the observed
low substrate specificity of YbtT, we hypothesized that this is
attributable to hydrolysis of productive, canonical thioester
intermediates. Indeed, when only canonical Ybt precursors
were made available to biosynthetic proteins, increasing YbtT
concentrations progressively diminished Ybt production
(Fig. 7B) to a degree (	20% lower yield with 50MYbtT) that
may not have been evident in the previous analysis (3). These
findings suggest that, whereas YbtT may maintain biosyn-
thetic activity by removing nonproductive thioesters from
HMWP2 and HMWP1, its low-specificity counterproduc-
tively can also reduce Ybt production by hydrolyzing canon-
ical Ybt precursors.
High in vivo YbtT expression diminishes Ybt production
Given that increasing YbtT concentrations can diminish in
vitroYbt biosynthesis, we hypothesized that physiological YbtT
expressionmust be optimized to balance hydrolysis of nonpro-
ductive thioesters with removal of productive, canonical Ybt
precursors from HMWP1 and HMWP2. To test this hypothe-
sis, we genetically complemented UTI89ybtT with a ybtT
expression vector under tight control by an arabinose-induci-
ble promoter. YbtT expression in arabinose-supplemented
medium was confirmed by Western blotting (data not shown).
In an iron-restricted medium with increasing arabinose con-
centrations, Ybt levels increased up to an arabinose concentra-
tion of 0.4% and decreased at concentrations exceeding 0.4%
(Fig. 7C). In contrast, increasing expression of the inactive
mutant ybtTS89A did not affect Ybt production (Fig. 7C). These
data are consistent with the existence of a cellular YbtT expres-
sion level at which competing productive and nonproductive
thioester hydrolysis rates lead to optimal Ybt production.
Structural comparison of YbtT to human TEII
Our results indicate that YbtT is required for optimal Ybt
production; hence, YbtT inhibition represents a candidate
therapeutic strategy for enterobacterial infections. To investi-
gate whether selective inhibition of this bacterial thioesterase is
feasible, we carried out initial structural analysis comparing
YbtT to human TEII (hTE2) (Fig. 8). The core hydrolase folds
for YbtT and hTE2 are very similar, with the major difference
being in the conformation of the structurally dynamic lid sub-
Figure 7. YbtT edits Ybt biosynthesis in vitro, and its expression must be regulated in vivo. A, time course of Ybt accumulation during full in vitro
reconstitution in the presence of the cognate substrate, Cys, and the noncognate substrate, Ser, with or without YbtT. Ybt levels are expressed as a percent
relative to the level reached in the Cys condition (black) at 120 min. Mean of n 3 with standard deviation plotted. B, Ybt accumulation during full in vitro
reconstitution in the presence of increasing concentrations of YbtT or YbtT–S89A. Ybt levels weremeasured at 10min and are expressed as a percent relative
to the 0M control. Mean of n 3with standard error plotted, one-way ANOVA comparedwithmultiple comparison post-test; ***, p 0.0001; ns, p 0.05. C,
Ybt levelswhen the isogenicmutantUTI89ybtTwas transformedwith either pBAD-ybtTor pBAD-ybtT-S89A andgrownunder iron-restricted conditions in the
presence of increasing concentrations of arabinose to induce expression of ybtT or ybtT-S89A. To account for the effects of arabinose, all of the data were
normalized by subtracting the Ybt levels of a vector-only control (pBAD) treatedwith the same concentrations of arabinose.Mean of n 3with standard error
plotted.
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domains (Fig. 8A). The YbtT lid subdomain is in the open con-
figuration, whereas the hTE2 structure is in a closed conforma-
tion, with the lid subdomain collapsed onto the active site (26).
This difference is indicated by the active-site cavity volumes
(YbtT 756 Å3; hTE2 128 Å3) (Fig. 8C). Comparisons of the
active-site cavities also indicate several differences in side chain
size, chemical nature, and charge between YbtT and hTEII in
the putative binding region for competitive inhibitors (Fig. 8B).
These observations suggest that YbtT-specific inhibitors with
decreased or little potency against hTE2 could be designed.
Discussion
In this study, we report the first structural and biochemical
characterization of YbtT, a TEII required for maximal in vivo
Ybt production, but unnecessary for maximal in vitro reconsti-
tution. Structural, biochemical, and bacterial culture studies
suggest that YbtT helps maintain HMWP1 andHMWP2 activ-
ity through a relatively nonspecific thioesterase activity that
removes nonproductive, inhibitory thioesters aberrantly incor-
porated into the Ybt biosynthetic pathway during bacterial
growth. YbtT slowly hydrolyzes a variety of productive and
erroneousmolecules fromHMWP1 andHMWP2CP domains.
The resulting free NRPS/PKS ppant thiols can then resume Ybt
biosynthesis. This is exemplified by YbtT-mediated restoration
of in vitro biosynthesis in the presence of a nonproductive pre-
cursor molecule.
Two models have been proposed for TEII editing of NRPS/
PKS pathways, specifically pertaining to the enzyme’s substrate
specificity at the level of the hydrolyzed small molecule (15, 17,
25). In the high-specificity model, the TEII specifically recog-
nizes noncognate precursors attached to CPs and hydrolyzes
these with high-catalytic efficiency. In the low-specificity
model, TEII hydrolyzes both cognate and noncognate precur-
sors fromCPswith low-catalytic efficiency. This low-specificity
model can be tolerated because flux through the pathway
greatly exceeds nonspecific hydrolysis or because cognate pre-
cursors are more strongly bound to the NRPS/PKS, shielding
them from hydrolysis.
The substrate profiling, in vitro reconstitution, and in vivo
overexpression results for YbtT are consistent with the low-
specificity editing model for Ybt biosynthesis. In cultured
E. coli, this is suggested by diminished Ybt production when
YbtT expression increases beyond an optimal level. During in
vitro reconstituted biosynthesis, the low-specificity model is
supported by diminished Ybt production upon YbtT addition
at 10-fold excess (100 M) and at longer time points in the
presence of only cognate precursors. The catalytic efficiency
(kcat/Km) of YbtT on p-NP acetate and butyrate was quite low,
although it is possible that it would be more active on other
p-NP ester substrates or other thioester substrates, such as acyl-
CPs. YbtT hydrolyzed both productive and nonproductive pre-
cursors to Ybt at the ArCP domain, including aromatic and
short acyl groups, with only a few exceptions. It was active on
salicylic acid, a correct building block of Ybt but not anthranilic
acid. It may be that replacing the 2-hydroxyl of salicylic acid
with an amino group, as in anthranilic acid, sterically hinders
substrate binding by YbtT. The ability of YbtT to hydrolyze
2,3-dihydroxybenzoyl-ArCP (a misincorporated enterobactin
biosynthetic intermediate) and to reverse L-serine-mediated
inhibition of Ybt biosynthesis is consistent with a role for YbtT
in removing physiologically relevant misincorporation errors
(34, 35). YbtT can thus hydrolyze both productive and nonpro-
ductive intermediates at NRPS CP domains.
In contrast to its mode of action at the pathway level, YbtT
activity at the PKS CP domain was more consistent with the
high-specificity editing model, avoiding malonyl thioester hy-
drolysis but readily hydrolyzing nonproductive acetyl and
hexanoyl thioesters. Similar PKS CP domain specificity was
observed in RifR and tylosin TEII, where substrate selectivity
was attributed to the absence of a terminal carboxyl group (17,
25). Acetyl thioesters may arise by spontaneous decarboxyla-
tion of malonyl thioesters. They may also arise during post-
Figure 8. ComparisonofYbtT tohumanTEII.A,overlay of crystal structures
YbtT WT (magenta) with human thioesterase II (hTE2, orange/gold, PDB code
4XJV). -Helices that compose the lid subdomain are labeled and colored
orange in hTE2. Position of the active site is denoted by the water occupying
the oxyanion hole (red sphere). B, comparison of structurally equivalent resi-
dues that line the putative active site and inhibitor pockets of YbtT and hTE2.
Residues labeled vary themost in either size, polarity, or charge between the
two structures. C, comparison of ppant cavities and entrance tunnels ana-
lyzed using CAVER, with coloring and labeling as in Fig. 3B. Cavity volumes
calculated by CAVER are YbtT 756 Å3 and hTE2 128 Å3.
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translationalmodification ofNRPS/PKSs through utilization of
an acetyl-CoA, rather than a free CoA, by the ppant transferase
(34). Nevertheless, low-specificity hydrolysis at other CP
domains likely dominates the overall picture duringYbt biosyn-
thesis, and YbtT acts as a low-specificity editor. It is possible
that YbtT inactivity onmalonyl-CP is a retained, vestigial func-
tion of an ancestral TEII that subsequently evolved with the
biosynthetic pathway to edit NRPS domains. It remains to be
determined whether the ability of YbtT to spare malonyl thio-
esters is due to the identity of the smallmolecule, the identity of
the CP domain, or a combination of both. Overall, our data
suggest that low-specificity editing of a multi-CP domain bio-
synthetic pathway may conceal high-specificity editing at spe-
cific CP domains. It also suggests that the low-specificitymodel
of editing may be a useful strategy for TEIIs that edit hybrid
NRPS/PKS pathways with many structurally unique precur-
sors, such as the Ybt biosynthetic pathway.
The crystal structures of YbtT provide a structural explana-
tion for the observed substrate specificity. Previous structural
and functional characterizations of RedJ (22) and RifR (25) have
noted that the chemical nature of residues in the lid subdomain
lining the active-site substrate pocket correlate with substrate
specificities. Specifically, this region of RedJ is rich in hydro-
phobic side chains, which would favor binding to the long-
chain acyl thioesters that are the preferred substrates for this
enzyme (22). In contrast, the same region of RifR containsmore
polar side chains, and correspondingly, RifR exhibits lower sub-
strate specificity (25). Our YbtT structure, like that of RifR, also
contains several polar and charged side chains in this region,
consistent with the low substrate specificity we observe. Our
structures also reveal that YbtT crystallized with the lid sub-
domain in an open conformation thatmay be stabilized by crys-
tal contacts, based on low relative B-factors. Such a conforma-
tion in solution would suggest ready access to the active site
and, hence, fast enzyme kinetics. However, YbtT displayed slow
enzyme kinetics. Previous crystallographic studies have noted
multiple conformations for the lid subdomain of TEIIs and
TEIs with this fold (22, 36). In addition, solution studies by
NMR indicate dynamics between the open and closed lid sub-
domain conformations (27, 37). Our kinetics results are sup-
portive of these previous observations, and access to the YbtT
active site may be controlled by the conformational dynamics.
Additionally, structural comparison to hTE2 shows that the
YbtT active-site pocket contains some vastly contrasting fea-
tures, suggesting that specific inhibition of YbtT might be
achieved without potently inhibiting hTE2.
The results of the pulldown with purified YbtT suggest that
this TEII interacts with HMWP1 and HMWP2 but not other
phosphopantetheinylated proteins in E. coli. There are few
reports on the protein–protein interactions between TEIIs and
the NRPSs and PKSs on which they act. EntH, the TEII from
enterobactin biosynthesis, was shown to interact with an ArCP
on one of the pathway’s NRPSs in a bacterial two-hybrid exper-
iment (38). The TEII involved with surfactin biosynthesis was
shown to bind a CP by NMR, and binding was enhanced when
the CP was phosphopantetheinylated and loaded with a small
molecule, although it should be noted that the CP that was used
did not come from the same biosynthetic pathway (27). Our
pulldown does not tell us whether YbtT is primarily interacting
with either HMWP1 or HMWP2, and it does not tell us pre-
cisely how these proteins interact, so this is an area for future
research. Our acyl-CP activity data do suggest that YbtT may
bind the ArCP and ACP domains because YbtT could hydro-
lyze small molecules from both. If TEIIs are scanning their cog-
nate NRPSs and PKSs, then these protein–protein interactions
may be very low affinity and difficult to quantify with standard
protein-binding techniques (39). The application of MS to
study TEII activity on CPs, as applied in this study, is very
revealing and further investigation of protein–protein interac-
tions may build upon this approach to understand the molecu-
lar mechanisms behind TEII substrate specificity for CP
domains.
Experimental procedures
Bacterial strains, culture conditions, and plasmid construction
The cystitis-derived UPEC model strain UTI89 was used
in this study (40, 41). The creation of the isogenic mutant
UTI89ybtT was previously described (14). UTI89fur was
generated using the Lambda Red recombinasemethod, and the
antibiotic cassette was subsequently removed (42). For growth
in iron-restricted conditions, strains were first grown for	18 h
in Luria-Bertani (LB) broth (BD Biosciences) at 37 °C under
rotating conditions. These cultures were then inoculated
1:1000 into M63 minimal media supplemented with 0.2% (v/v)
glycerol and 10mg/ml niacin (Sigma) and grown at 37 °C under
rotating conditions for	18 h. Ampicillin (100g/ml, Goldbio)
was used for plasmid selection, where appropriate. Arabinose
was added at inoculation to induce YbtT and YbtT–S89A
expression during the 18-h M63 growth in the YbtT overex-
pression study.
Plasmids for YbtT expression studies and protein purifica-
tion were constructed using the vector backbones pTrcHis2
(Invitrogen) and pBAD/Myc-His (Invitrogen) and standard
molecular biology techniques, including PCR and the restric-
tions enzymes NcoI and HindIII (New England Biolabs). The
S89A andH225Amutants were generated with a standard site-
directedmutagenesis kit (Quikchange, Agilent). pET22b-ArCP
and pET22b-YbtUwere constructed as described previously (3,
43). YbtE was cloned into a pET28a vector with an N-terminal
His6 tag using NdeI and XhoI restriction sites. YbtT, ArCP,
YbtU, and YbtE were all cloned from the UTI89 genome. All
other plasmids for ACP, Sfp, HMWP1, and HMWP2 expres-
sion were kind gifts from Dr. Tim Wencewicz and the Walsh
strain collection.
Recombinant protein expression and purification
pTrcHis2 expression plasmids of YbtT, YbtT–S89A, YbtT–
D197A, and YbtT–H225A with a C-terminal Myc (EQKLISEEDL)-
His6 tag were expressed in the BL21(DE3) E. coli strain. The
expression strains were grown overnight in LB at 37 °C, and
then back-diluted 1:50 into 3 liters of LB supplemented with
100 g/ml ampicillin. The cultures were grown at 37 °C to OD
0.4–0.6 and then induced with 1 mM isopropyl -D-thiogalac-
topyranoside (IPTG, Goldbio) for 4 h at 37 °C. The cells were
resuspended in lysis buffer (20mMTris (pH 8.0), 300mMNaCl,
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5mM-mercaptoethanol, 5mM imidazole) at a ratio of 10ml of
buffer to 1 liter of culture and then stored at80 °C.
For YbtT, YbtT–S89A, YbtT–D197A, and YbtT–H225A
purification, the resuspended cell pellets were thawed; rotated
for 30 min at room temperature with 1 mg/ml lysozyme
(Sigma), 2 g/ml DNase I (Sigma), and 2 mM MgSO4; and son-
icated. The lysate was isolated by centrifugation at 12,000 
 g
for 1 h at 4 °C (Beckman Coulter); filtered through a 0.44-m
filter (Millipore); run over a column of Ni-NTA–agarose beads
(Goldbio); and washed with 20mMTris (pH 8.0), 300mMNaCl,
5 mM -mercaptoethanol, 20 mM imidazole; and the protein
was eluted with 20 mM Tris (pH 8.0), 300 mM NaCl, 5 mM
-mercaptoethanol, 300 mM imidazole. The elutions were
pooled, concentrated in a 10-kDa cutoff Vivaspin 20 concentra-
tor (Sartorius), and further purified on a 16/600 Superdex 75 pg
gel filtration column (GE Bio-Sciences) equilibrated with run-
ning buffer (50 mM potassium phosphate (pH 7.4, Sigma), 100
mM KCl (Sigma), 2 mM tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP, Goldbio)). In the case of YbtT–D197A, the
running buffer contained 300 mM KCl. Fractions containing
YbtT or the respective mutant were confirmed by SDS-PAGE
andCoomassie Blue staining, pooled, concentrated in a 10-kDa
cutoff Vivaspin 20 concentrator, and dialyzed into storage
buffer (50 mM potassium phosphate (pH 7.4), 100 mM KCl, 2
mM TCEP, 10% glycerol) overnight at 4 °C in a 3-ml 2000
MWCO dialysis cassette. After dialysis, proteins were flash-
frozen and stored at80 °C.
For YbtE purification, the expression vectorwas transformed
into Rosetta D3 E. coli cells. The cells were grown at 37 °C to an
OD	1.0 and then induced with 250 mM IPTG for 5 h at 30 °C.
Cells were pelleted and resuspended in 150 mM NaCl, 10 mM
Tris (pH 8.5), 50 mM K2HPO4, 5 mM imidazole, and 10 mM
-mercaptoethanol supplemented with lysozyme and DNase.
They were lysed by sonication, and the debris was pelleted by
centrifugation for 30 min at 16,000
 g. The supernatants were
passed over Ni-NTA super flow resin (Qiagen); washed with
300 mM NaCl, 20 mM imidazole, and 50 mM K2HPO4 (pH 8.0);
and then eluted in 300mMNaCl, 250mM imidazole, and 50mM
K2HPO4 (pH 8.0). Eluted protein was further purified by size-
exclusion chromatography on a Superdex 16/600 S75 column
(GE Bio-Sciences) in 20 mM HEPES and 150 mM NaCl with 1
mM dithiothreitol (DTT).
Purification of ArCP and ACP in their apo and holo states
was performed as described previously (43, 44). Purification of
Sfp was also performed as described previously (45). HMWP2,
HMWP1, and YbtU were expressed and purified as described
previously, with minor modifications (3, 46, 47).
For HMWP2 purification, the BL21(DE3) E. coli strain
expressing pHMWP2.CH8was grown in 2
YT broth contain-
ing 2mMMgCl2 at 37 °C toOD 0.4, thenmoved to 16 °C, and at
OD0.8 inducedwith 50M IPTG for 16h at 16 °C. ForHMWP1
purification, the BL21(DE3) E. coli strain expressing pET28b–
HMWP1was grown in LB at 37 °C toOD 0.6, and then induced
with 75 M IPTG for 16 h at 16 °C. For both proteins, the cells
were resuspended in lysis buffer (20 mM Tris (pH 8.0), 500 mM
NaCl, 5 mM -mercaptoethanol, 1 mM phenylmethylsulfonyl
fluoride (PMSF, Sigma), EDTA-free protease inhibitor mixture
tablet (SIGMAFASTTM), 5 mM imidazole) at a ratio of 15 ml of
buffer to 1 liter of culture and then stored at80 °C. The lysates
were obtained as described above and incubated in batch with
Ni-NTA–agarose beads overnight at 4 °C. The beads were then
packed into a column and washed with buffer (20 mM Tris (pH
8.0), 500 mM NaCl, 5 mM -mercaptoethanol, 1 mM PMSF)
containing 5 mM imidazole and 20 mM imidazole, sequentially;
and the proteinwas elutedwith buffer and a gradient from30 to
100 mM imidazole. All steps were performed at 4 °C. The elu-
tions containing HMWP2 or HMWP1 were pooled, concen-
trated in a 100,000 concentrator (Amicon), and further purified
on aMono QHR 5/5 anion-exchange column (GE Healthcare)
with running buffer A (20 mM Tris (pH 8.0), 5 mM -mercap-
toethanol) and running buffer B (20mMTris (pH8.0), 1 MNaCl,
5mM-mercaptoethanol). Fractions containing the target pro-
tein were analyzed, concentrated, dialyzed into storage buffer
(25 mM Tris (pH 8.0), 2 mM TCEP, 10% glycerol), flash-frozen,
and stored at80 °C, as described above.
For YbtU, the BL21(DE3) E. coli strain expressing pET22b-
YbtU was grown at 22 °C without IPTG induction for 24 h and
resuspended in lysis buffer described for HMWP2 and
HMWP1. YbtU was purified over Ni-NTA as described for
YbtT, except 500 mM NaCl was included in all buffers. It was
further purified on a 16/600 Superdex 200 pg gel-filtration col-
umn (GE Bio-Sciences) in 20mMTris (pH 8.0), 500mMNaCl, 5
mM -mercaptoethanol. The storage buffer contained 25 mM
Tris (pH 8.0), 100 mM NaCl, 2 mM TCEP, 10% glycerol.
Crystallization, data collection, and structure determination
For crystallization, YbtT and YbtT–S89A were purified as
described above and concentrated to 15 or 17 mg/ml for WT
and S89A, respectively, in 20 mM HEPES (pH 7.4), 150 mM
NaCl, and 1 mM DTT. Crystals of WT and S89A YbtT were
obtained by mixing the concentrated protein solution with
reservoir solution (either 200 mM tri-sodium citrate, 21%
PEG 3350, 0.5% n-dodecyl--D-maltoside (S89A) or 200 mM
di-ammonium hydrogen citrate, 20% PEG 3350 (WT)) in a
1:1 ratio. Crystals routinely formed over the course of 2–4
days. Crystals were cryoprotected in reservoir solution sup-
plemented with 20% ethylene glycol and stream-frozen at
100 K. X-ray diffraction data were collected at the Advanced
Light Source beamline 4.2.2 at Lawrence Berkeley National
Laboratory. Crystals contained one molecule in the asym-
metric unit with 43% solvent content. Data were processed
using XDS (48). Data collection and refinement statistics are
given in Table 1.
The phase problem was solved by molecular replacement in
the program PHASER (49) using a polyalanine model of the
S. coelicolor thioesterase RedJ (PDB code 3QMW(22)). Follow-
ing rigid body refinement, themodelwas built by a combination
of auto-rebuilding with PHENIX (50) using RESOLVE (51) and
manual building in COOT (52). WT and S89A YbtT were
refined against data to 1.9 and 1.4 Å, respectively, using
PHENIX. Hydrogens were generated in the final stages of
refinement and included as a riding model. The final model for
both WT and S89A consisted of residues 1–248. All residues
are within the most favored (98.0/97.6%) and additional
allowed regions (2.0/2.4%) of a Ramachandran plot.Molprobity
scores were 1.08/1.00, and clash scores were 2.86/2.08 for the
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final models ofWT/S89A YbtT, respectively. Molecular graph-
ics figures were created using PyMOL. All crystallographic and
analysis software used were compiled and distributed by the
SBGrid resource (53), and diffraction images were archived
with the SBGrid Data Bank (54). The coordinates and experi-
mental structure factors of WT and S89A have been deposited
in the RCSB Protein Data Bank and assigned the PDB codes
6BA8 and 6BA9, respectively.
p-NP acetate, p-NP butyrate, and glycine p-nitroanilide
activity assays
Enzymatic assays were performed as described previously
(17, 30). All substrates were from Sigma. Reactions were per-
formed in 1-ml cuvettes at 30 °C in 50mMpotassiumphosphate
(pH 7.4). All reactions contained 5% DMSO (v/v), as it was the
vehicle for solubilizing the substrates. YbtT and mutants
were used at 0.5 M, and substrates were used at variable
concentrations in excess of enzyme. All reaction compo-
nents except substrate were pre-incubated at 30 °C for 5 min
to reach temperature, and then the reactions were initiated
by adding substrate and mixing. Time courses with p-NP
acetateandp-NPbutyratewerecollectedbymonitoringabsor-
bance at 405 nm, and the product concentration was calcu-
lated with   18,000 M1 cm1 (manufacturer’s protocol).
Time courses with glycine p-nitroanilide were collected by
monitoring absorbance at 405 nm, and the product concen-
tration was calculated with   9500 M1 cm1 (55). Data
were corrected for background spontaneous hydrolysis
in the absence of enzyme. Analysis was performed with
GraphPad Prism 4 (GraphPad Software). Because p-NP-bu-
tyrate had limited solubility and saturation could not be
reached, a full Michaelis-Menten analysis could not be per-
formed. The kcat/Km value reported was estimated from the
reaction progress curve, as described by Copeland (56).
Ybt detection in bacterial culture
Ybt was detected in spent supernatants by stable isotope
dilution after growth under iron-restricted conditions. A 13C-
Ybt internal standard was prepared by growing UTI89 in M63
minimal media supplemented with 0.2% (v/v) 13C3-glycerol
(Sigma) and 10 mg/ml niacin, as described previously (2). After
bacterial growth, 25l of 13C-Ybt internal standard (4) and 6l
of 0.5 M FeCl3 were added to 1 ml of culture supernatant. The
samples were extracted on C18 silica columns (United
Chemical Technologies) with 80% methanol (Sigma). Ybt
was detected using a multiple reaction monitoring method on
a Shimadzu Prominence UFLC-coupled AB Sciex QTrap 4000
mass spectrometer with a Turbo V electrospray ionization
source. The LC separation was performed with an Ascentis
Express phenyl–hexyl column (100 
 2.1 mm, 2.7 M;
Sigma) and the mobile phases: A  HPLC-grade water 
0.1% (v/v) formic acid (Sigma) and B  90% acetonitrile
(EMD Millipore)  0.1% (v/v) formic acid. All LC and MS
settings were the same as described previously (57). Ybt lev-
els were assessed by taking the peak area ratio of the native
isotope Fe–Ybt to the internal standard Fe–13C-Ybt.
Pulldown and protein identification by LC-MS/MS
The UTI89fur lysate was obtained by growing the strain at
37 °C overnight; back-diluting it into 1 liter of fresh LB and
growing at 37 °C shaking for 18 h; pelleting the cells at 8000 rpm
for 10 min, 4 °C (Beckman Coulter); discarding the superna-
tant; resuspending the cell pellet in 10 ml of loading buffer (20
mM Tris (pH 8.0), 300 mM NaCl, 5 mM -mercaptoethanol, 10
mM imidazole); and freezing the resuspension at80 °C. After
thawing the cell pellet, it was lysed and clarified as described for
protein purification,with the exception that an additional 30ml
of lysis buffer was added after treatment with lysozyme and
DNase I but prior to sonication. Threemini-spin columns were
prepared with a 50-l bed volume of Ni-NTA beads. Two of
these columnswere loadedwith 0.5mg of purified YbtT–Myc–
His, and one was mock-treated with YbtT storage buffer
(described above) to serve as a prey-only control. Loading of
YbtT (bait) was performed by rotating the columns for 15
min at 4 °C. Excess bait was washed away with 500 l of
loading buffer. 1500 l of UTI89fur lysate (prey) was added
to one YbtT-loaded column and the mock-treated column.
The remaining YbtT-loaded column was treated with 1500
l of loading buffer as a bait-only control. The columns were
rotated at 4 °C overnight and washed twice with 500 l of
YbtT wash buffer (see above), and protein complexes were
eluted with 100 l of YbtT elution buffer (see above). The
elutions from the three columns were analyzed by SDS-
PAGE and SYPROOrange staining according to the manufa-
cturer’s protocol (Sigma).
To identify the proteins pulled down by YbtT, the gel bands
at 250 and 250 kDa were excised and digested with trypsin
overnight. The extracted peptides were dried down and redis-
solved in 10 l of 5% acetonitrile, 0.1% formic acid. 5 l were
injected and run on an LTQ-Orbitrap Velos Pro using a 1-h
gradient on aDionex RSLCnanoHPLCwith a 0.075
 250-mm
C18 Waters CSH130 1.7-m, 130 Å column. All MS/MS sam-
ples were analyzed usingMascot (Matrix Science, London, UK;
version 2.5.0).Mascotwas set up to search theNCBInr database
(selected for E. coli, 1,210,071 entries) assuming the digestion
enzyme trypsin.Mascot was searchedwith a fragment ionmass
tolerance of 0.60 Da and a parent ion tolerance of 10.0 ppm.
Deamidation of asparagine and glutamine, oxidation of methi-
onine, carbamidomethyl of cysteine, and phosphopantetheiny-
lation of serine were specified in Mascot as variable modifica-
tions. Scaffold (version Scaffold_4.4.0, Proteome Software Inc.,
Portland, OR) was used to validate MS/MS-based peptide and
protein identifications. Peptide identifications were accepted if
they could be established at greater than 80.0% probability by
the Scaffold local false discovery rate algorithm. Protein identi-
fications were accepted if they could be established at greater
than 99.0% probability and contained at least two identified
peptides.
ArCP and ACP acylation
Protocols for enzymatic acylation of CPs were developed from
past reports (43, 58, 59). Reactions were performed in 50 mM
potassium phosphate (pH 7.4)  100 mM KCl. ArCP acylation
reactions performed with YbtE included: 1 M YbtE, 500 M aryl
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acid, 10 mM MgCl2, 2 mM TCEP, 1 mM ATP, and 25 M holo-
ArCP. ArCP and ACP acylation reactions performed with Sfp
included: 1 M Sfp, 20 M acyl-CoA, 10 mMMgCl2, 2 mM TCEP,
and 20Mapo-ACPorArCP.All reactionswere incubated for 2 h
at 37 °C, and then excess substrate was removed with 7K Zeba
desalting columns (ThermoFisher Scientific). The acylation was
confirmedby full scanLC-MS(instrumentdetails above) toobtain
a deconvoluted observed molecular weight (Analyst and Mag-
Tran) and by the ppant ejectionmethod (32, 33).
LC-MS-based YbtT assay on ArCP and ACP
Activity assays were performed in a 100-l reaction volume
with 20 M acyl-CP substrate and 1 M YbtT (or YbtT storage
buffer as a negative control) in 50 mM potassium phosphate (pH
7.4) 100mMKCl 2mMTCEP. The reactions were incubated
for 30 min at 37 °C. The samples were diluted 1:2 with 100 mM
ammonium bicarbonate and immediately analyzed by LC-MS
(instrument details above) in a positive ion mode with an
enhanced resolution scan centered on the12 charge state of the
protein.
Ybt in vitro reconstitution
A solution of 5MYbtE, 5MHMWP2, 5MHMWP1, 5M
YbtU, 0.5 M Sfp, 100 mM Tris (pH 8.0), 10 mM MgCl2, 1 mM
TCEP, 100 M CoASH, 2 mM L-cysteine, 0.75 mM SAM, 0.75
mM NADPH, 1 mM malonyl-CoA, and 2 mM salicylic acid was
incubated at 30 °C for 0.5 h to allow for phosphopantetheinyla-
tion of HMWP2 and HMWP1. In the case of YbtT rescue
experiments, 1.5 mM L-cysteine and 30 mM L-serine were used.
Then, 50 M YbtT, YbtT–S89A, or YbtT storage buffer
(described above) was added. 10 mM ATP was immediately
added to initiate the reaction, and reactionmixtures were incu-
bated at 30 °C. 20-l aliquots of the reactions were quenched at
the designated time point with 10 l of 10% formic acid. To
extract Ybt for quantification, 100 l of acetonitrile and 5 l of
13C-Ybt internal standard were added, and the mixtures were
vortexed rigorously for 30 s; centrifuged at 14,000 
 g for 15
min at 4 °C; and the supernatant was analyzed by LC-MS/MS
(see above).
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